专家意见与狼疮低疾病活动状态操作定义的一致性:基于病例的结构效度研究
该研究基于50例真实SLE病例摘要,由50名国际风湿病专家独立评估疾病活动状态,并与LLDAS操作定义进行一致性分析。总体一致性为77.96%(95%CI 76.34-79.58%),Cohen's kappa为0.57(95%CI 0.55-0.61)。LLDAS操作定义较专家意见在定义低疾病活动状态时更为严格。
要点
- LLDAS操作定义与专家意见总体一致性为77.96%,kappa为0.57。
- 符合LLDAS的病例中仅5.34%被专家评为中/高活动度。
- 不符合LLDAS的病例中35.14%被专家评为缓解/低活动度。
核心结论
- LLDAS具有良好的结构效度,操作定义与专家意见总体一致性高。
- 不一致结果提示LLDAS操作定义在定义低疾病活动状态时较专家意见更严格。
研究设计与样本
- 基于50例真实SLE患者病例摘要,由50名未参与LLDAS项目的国际风湿病专家独立评估疾病活动状态。
- 采用Cohen's kappa评估专家意见与LLDAS操作定义之间的一致性。
主要发现
- 专家意见与LLDAS操作定义总体一致性为77.96%(95%CI 76.34-79.58%),Cohen's kappa为0.57(95%CI 0.55-0.61)。
- 不一致常见原因包括:将泼尼松龙剂量高于LLDAS定义(≤7.5mg)的病例评为缓解/低活动度,或因血清学活动(高抗dsDNA抗体和/或低补体)导致SLEDAI-2K>4的病例评为缓解/低活动度。
关键数值与推荐
- LLDAS操作定义中泼尼松龙剂量阈值为≤7.5mg。
- SLEDAI-2K>4 due to serological activity(高抗dsDNA抗体和/或低补体)为不符合LLDAS的常见原因。
临床怎么用
- LLDAS可作为SLE治疗目标,其操作定义与专家意见一致性良好。
- 临床评估低疾病活动状态时需注意LLDAS较专家意见更严格,尤其关注激素剂量和血清学活动。
局限性
- 研究基于病例摘要而非真实患者直接评估,可能影响结果外推。
- 专家评估者未参与LLDAS项目,但其意见仍可能受LLDAS概念影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the construct validity of the Lupus Low Disease Activity State (LLDAS), a treatment target in systemic lupus erythematosus (SLE). METHODS: Fifty SLE case summaries based on real patients were prepared and assessed independently for meeting the operational definition of LLDAS. Fifty international rheumatologists with expertise in SLE, but with no prior involvement in the LLDAS project, responded to a survey in which they were asked to categorize the disease activity state of each case as remission, low, moderate, or high. Agreement between expert opinion and LLDAS was assessed using Cohen's kappa. RESULTS: Overall agreement between expert opinion and the operational definition of LLDAS was 77.96% (95% CI: 76.34-79.58%), with a Cohen's kappa of 0.57 (95% CI: 0.55-0.61). Of the cases (22 of 50) that fulfilled the operational definition of LLDAS, only 5.34% (59 of 22 × 50) of responses classified the cases as moderate/high activity. Of the cases that did not fulfill the operational definition of LLDAS (28 of 50), 35.14% (492 of 28 × 50) of responses classified the cases as remission/low activity. Common reasons for discordance were assignment to remission/low activity of cases with higher corticosteroid doses than defined in LLDAS (prednisolone ≤ 7.5mg) or with SLEDAI-2K >4 due to serological activity (high anti-dsDNA antibody and/or low complement). CONCLUSIONS: LLDAS has good construct validity with high overall agreement between the operational definition of LLDAS and expert opinion. Discordance of results suggests that the operational definition of LLDAS is more stringent than expert opinion at defining a low disease activity state.
引用
- Golder V, Huq M, Franklyn K, et al. Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study. Semin Arthritis Rheum. 2017. PMID: 28216192. doi:10.1016/j.semarthrit.2017.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。